Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Vaccines|April 27, 2024
Intranodal Injection of Immune Activator Demonstrates Antitumor Efficacy in an Adjuvant ApproachRomano Josi, Anete Ogrina, Dominik Rothen, et al.
Viruses|September 27, 2025
Versatile and Scalable Nanoparticle Vaccine as a Scaffold Against Newly Emerging Influenza VirusesAlessandro Pardini, Dominik A Rothen, Pascal S Krenger, et al.
Iscience|March 25, 2024
A tetravalent nanovaccine that inhibits growth of HPV-associated head and neck carcinoma via dendritic and T cell activationRomano Josi, Daniel E Speiser, Simone de Brot, et al.
Vaccines|August 29, 2024
Green Routes: Exploring Protein-Based Virus-like Nanoparticle Transport and Immune Activation in Nicotiana benthamiana for Biotechnological ApplicationsRomano Josi, Alessandro Pardini, Alexander Haindrich, et al.
NPJ Vaccines|June 13, 2025
Regulatory T cells define affinity thresholds for CD8+ T cell tumor infiltrationMona O Mohsen, Romano Josi, Sanjana V Marar, et al.
Vaccines|September 27, 2025
Targeted Lymph Node Immunization with Serotype-Specific Dengue VLP Vaccines Enhances Antibody Avidity and SpecificityDominik A Rothen, Alessandro Pardini, Sudip Kumar Dutta, et al.
Allergy|October 10, 2023
Influence of antigen density and TLR ligands on preclinical efficacy of a VLP-based vaccine against peanut allergyPascal S Krenger, Romano Josi, Jan Sobczak, et al.
Vaccines|September 28, 2024
Preclinical Development of a Novel Zika Virus-like Particle Vaccine in Combination with Tetravalent Dengue Virus-like Particle VaccinesDominik A Rothen, Sudip Kumar Dutta, Pascal S Krenger, et al.
Allergy|September 8, 2021
A scalable and highly immunogenic virus-like particle-based vaccine against SARS-CoV-2Mona O Mohsen, Ina Balke, Simon Zinkhan, et al.
Pageof 1